A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples